Researchers are excited about the medication , a novel dual compound showing significant results in initial trials for weight reduction . It acts by targeting both pathways : GLP-1 and GIP, these, when https://sashatqtd761458.educationalimpactblog.com/62301233/a-new-possibility-for-size-loss